Every year, hundreds of billions of dollars are invested to discover and develop new therapies, yet the financial infrastructure behind that work has not kept pace. Clinical operations and finance live in disconnected worlds, forcing teams to make high-stakes decisions using fragmented tools and static data.
Condor exists to change that. We are a system of action, building the financial intelligence layer that will power the next era of clinical development. Condor connects clinical operations, vendor activity, and financial signals into a single, real-time intelligence layer, giving R&D and finance leaders true command over how their organizations operate. Our platform is pharma-native, AI-driven infrastructure — built around an operation layer of guarded, audited business logic, a bitemporal source of truth, and AI agents that reason over real clinical and financial data. We are a high-growth Series A company backed by Insight Partners, Felicis, and 645 Ventures, growing rapidly with Top 200 biopharma companies.